A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
ton University. The conference brought together leaders from academia, industry, and government to (1) discuss personalized medicine's current and potential impact on cardiovascular patient outcomes; (2) review emerging technologies and applications that may shape the field in the future; (3) discuss the results of an American College of Cardiology survey examining personalized medicine adoption rates among US cardiologists; (4) identify the barriers to adoption of pharmacogenetics-baseddoi:10.1161/jaha.111.000554 pmid:23130127 pmcid:PMC3487365 fatcat:b67sxx5ryvbtzbum6wsxyg3k5e